Detecting leukemia usually starts with a routine complete blood count (CBC) that shows abnormal white cell numbers, anemia, or low platelets. A blood smear then looks for immature blast cells, and a bone marrow biopsy with flow cytometry and genetic testing confirms the diagnosis and identifies the exact subtype. That subtype matters, because it decides the treatment.
This guide covers what leukemia is, the warning signs, and each step of the diagnostic workup, written for clinicians and students as well as patients who want to understand their tests.
What Is Leukemia?
Leukemia is a cancer of the blood-forming tissue, which begins in the bone marrow. A mutated blood-forming cell multiplies as a clone, producing abnormal blood cells that do not work properly and crowd out healthy cell production.
It mainly affects leukocytes, the white blood cells that defend against infection. As the marrow fills with leukemic cells, production of red cells and platelets falls, which explains many of the symptoms.
The Four Main Types
Leukemia is classified by speed (acute or chronic) and by the cell line involved (myeloid or lymphoid). For a fuller look at the biology, see how leukemia develops.
| Type | Typical patient | Key detection clue |
|---|---|---|
| Acute lymphoblastic leukemia (ALL) | Mostly children | Lymphoblasts in blood or marrow |
| Acute myeloid leukemia (AML) | Mostly older adults | Myeloblasts; blasts of 20% or more in marrow or blood for most cases |
| Chronic lymphocytic leukemia (CLL) | Older adults | Persistently raised mature-looking lymphocytes, often found incidentally |
| Chronic myeloid leukemia (CML) | Middle-aged adults | High white count with a left shift; Philadelphia chromosome (BCR-ABL1) |
Risk Factors Worth Knowing
Most people with leukemia have no identifiable cause. Recognized risk factors include:
- Previous chemotherapy or radiation therapy for another cancer
- High-dose ionizing radiation exposure
- Long-term exposure to benzene
- Smoking (for AML)
- Genetic conditions such as Down syndrome, and rare familial leukemia syndromes
- Pre-existing blood disorders, such as myelodysplastic syndromes
Increasing age is the strongest risk factor for AML and CLL, whereas ALL peaks in early childhood.
Signs and Symptoms That Prompt Testing
Symptoms follow from marrow failure and from leukemic cells spreading into tissues. Acute leukemias develop over days to weeks; chronic leukemias are often found on a blood test before any symptoms appear.
- Anemia: fatigue, breathlessness, pallor
- Low platelets: easy bruising, nosebleeds, bleeding gums, pinpoint red spots (petechiae)
- Low functional white cells: frequent or severe infections, fever
- Tissue infiltration: bone pain, swollen lymph nodes, enlarged spleen or liver, gum swelling
- General symptoms: night sweats, unexplained weight loss
How to Detect Leukemia: The Diagnostic Pathway
Detection is stepwise. Each test either raises or lowers suspicion and guides the next step.
1. Complete Blood Count
The CBC is the usual first clue. The white count may be high, normal, or low; leukemia is not ruled out by a normal white count. Unexplained anemia plus low platelets, or any circulating blasts, needs urgent review.
2. Peripheral Blood Smear
A trained eye examines stained blood under the microscope. Blasts, Auer rods (a hallmark of myeloid blasts), smudge cells in CLL, or a full spectrum of maturing myeloid cells in CML all point toward a diagnosis.
3. Bone Marrow Aspirate and Biopsy
A sample is taken, usually from the back of the hip bone under local anesthetic. The aspirate shows cell detail and blast percentage; the core biopsy shows marrow structure and cellularity. For most acute leukemias, marrow examination is essential.
4. Flow Cytometry (Immunophenotyping)
Flow cytometry reads the surface markers on cells to confirm their lineage, for example distinguishing myeloid from B- or T-lymphoid blasts. In CLL, flow cytometry of blood alone is often enough for diagnosis.
5. Cytogenetics and Molecular Testing
Karyotyping, FISH, PCR, and next-generation sequencing detect chromosome changes and gene mutations. Examples include BCR-ABL1 in CML, and FLT3 and NPM1 mutations in AML. These results refine classification, predict prognosis, and identify targeted treatments.
6. Supporting Tests
Coagulation studies (important in acute promyelocytic leukemia), kidney function, uric acid, and LDH assess complications. A lumbar puncture checks for spread to the spinal fluid in ALL, and imaging is used selectively.
Common Pitfalls in Detection
Several situations can delay the diagnosis. A normal or low white count with unexplained anemia and low platelets is easy to attribute to a viral infection or a nutritional problem. Symptoms such as tiredness and bone pain are vague and often blamed on everyday causes.
Leukemia can also be confused with conditions that produce abnormal blood counts, including severe infection, vitamin B12 deficiency, and other marrow disorders such as myelodysplastic syndromes. When a blood count does not fit a clear explanation, or does not recover on repeat testing, referral to hematology is the safe course. Blasts on a smear, or a very high white count with symptoms, warrant same-day review.
After Detection: Treatment Overview
Treatment depends on the subtype and genetic profile, as well as age and fitness.
- Chemotherapy: the backbone of treatment for acute leukemias.
- Targeted therapy: tyrosine kinase inhibitors such as imatinib have transformed CML; other targeted drugs are used in AML and CLL.
- Immunotherapy: including antibody-based treatments and CAR T-cell therapy in selected cases.
- Stem cell transplantation: replaces diseased marrow and offers a chance of cure for some higher-risk patients.
- Watchful waiting: many people with early CLL need no treatment for years.
After treatment, measurable residual disease testing uses flow cytometry or molecular methods to detect very small numbers of remaining leukemic cells, guiding further therapy.
Key Takeaways
- A CBC is the first step in detecting leukemia, but a normal white count does not exclude it.
- Blasts in the blood, or unexplained anemia with low platelets, need urgent hematology review.
- Bone marrow examination, flow cytometry, and genetic tests confirm the diagnosis and the subtype.
- Genetic results now directly shape treatment choices and prognosis.
Frequently Asked Questions
Can a routine blood test detect leukemia?
A CBC often shows the first sign, such as abnormal white cells, anemia, or low platelets, and chronic leukemias are frequently found this way. However, a blood count alone cannot confirm leukemia; further tests are needed.
Is a bone marrow biopsy always needed?
For acute leukemia it almost always is. In CLL, flow cytometry of the blood can be sufficient, and in CML the diagnosis can often be made from blood molecular testing, though marrow is usually examined to stage the disease.
How quickly are results available?
The CBC and smear are usually available within hours, flow cytometry within a day or two, and full genetic results can take longer. Urgent treatment for acute leukemia often begins before every result is back.
Does a high white blood cell count mean leukemia?
No. Infection, inflammation, steroids, and stress commonly raise the white count. The pattern of cells on the smear, rather than the number alone, is what raises concern. Our leukemia guide covers each type in more depth.
